Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential
Explore the exciting world of Neurocrine Biosciences (NASDAQ: NBIX) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of Feb. 19, 2025. The video was published on March 26, 2025.Continue readinghttps://www.fool.com/investing/2025/03/26/neurocrine-biosciences-a-smart-biotech-bet-with-bl/
Googlers grilled leaders about smaller pay bumps in a recent all-hands
At a recent Google all-hands meeting, employees question leadership on 2025 compensation packages.
MicroVision, Inc. (MVIS) Q4 2024 Earnings Call Transcript
https://seekingalpha.com/article/4770700-microvision-inc-mvis-q4-2024-earnings-call-transcript
CFO evolution puts spotlight on data, tech skills
https://finance.yahoo.com/news/cfo-evolution-puts-spotlight-data-150506235.html
Concentrix Corporation (CNXC) Q1 2025 Earnings Call Transcript
https://seekingalpha.com/article/4770699-concentrix-corporation-cnxc-q1-2025-earnings-call-transcript
3 Reasons American Express Is a Long-Term Buy for 2030 and Beyond
Although growth stocks have a place in many portfolios, even young, risk-tolerant investors should own some long-term value stocks. These stocks that you can count on give you the flexibility to invest some of your other funds in higher-risk, higher-growth potential stocks, since they minimize the overall risk of your entire portfolio.American Express (NYSE: AXP) has been around since 1850 — that’s quite a track record of success. It’s a top stock with a differentiated model and long-term growth drivers, and it offers stability for any kind of investor. Here are three reasons to buy it now and hold it for at least five years.American Express has created a brand that targets the affluent consumer, and this customer base is more resilient than the average person. That provides some security for American Express, and it has continued to report healthy, profitable growth despite the inflationary environment. Revenue increased 10% year over year (currency neutral) in 2024, and earnings per share were up 25% to $14.01. CEO Stephen Squeri noted that momentum increased toward the end of the year with a strong holiday season.Continue readinghttps://www.fool.com/investing/2025/03/26/3-reasons-american-express-is-a-long/
Concentrix Corporation 2025 Q1 – Results – Earnings Call Presentation
https://seekingalpha.com/article/4770698-concentrix-corporation-2025-q1-results-earnings-call-presentation?source=feed_all_articles
Usio, Inc. (USIO) Q4 2024 Earnings Call Transcript
https://seekingalpha.com/article/4770697-usio-inc-usio-q4-2024-earnings-call-transcript
Snail, Inc. (SNAL) Q4 2024 Earnings Call Transcript
https://seekingalpha.com/article/4770696-snail-inc-snal-q4-2024-earnings-call-transcript
Trump tariffs spook markets, but investor confidence grows
https://finance.yahoo.com/news/trump-tariffs-spook-markets-investor-150000583.html